Cargando…
Efficient antibody evasion but reduced ACE2 binding by the emerging SARS-CoV-2 variant B.1.640.2
| Autores principales: | , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9110932/ https://www.ncbi.nlm.nih.gov/pubmed/35581351 http://dx.doi.org/10.1038/s41423-022-00870-5 |
| _version_ | 1784709213617913856 |
|---|---|
| author | Arora, Prerna Kempf, Amy Nehlmeier, Inga Graichen, Luise Schulz, Sebastian Cossmann, Anne Dopfer-Jablonka, Alexandra Winkler, Martin S. Jäck, Hans-Martin Behrens, Georg M. N. Pöhlmann, Stefan Hoffmann, Markus |
| author_facet | Arora, Prerna Kempf, Amy Nehlmeier, Inga Graichen, Luise Schulz, Sebastian Cossmann, Anne Dopfer-Jablonka, Alexandra Winkler, Martin S. Jäck, Hans-Martin Behrens, Georg M. N. Pöhlmann, Stefan Hoffmann, Markus |
| author_sort | Arora, Prerna |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9110932 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Nature Publishing Group UK |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-91109322022-05-17 Efficient antibody evasion but reduced ACE2 binding by the emerging SARS-CoV-2 variant B.1.640.2 Arora, Prerna Kempf, Amy Nehlmeier, Inga Graichen, Luise Schulz, Sebastian Cossmann, Anne Dopfer-Jablonka, Alexandra Winkler, Martin S. Jäck, Hans-Martin Behrens, Georg M. N. Pöhlmann, Stefan Hoffmann, Markus Cell Mol Immunol Correspondence Nature Publishing Group UK 2022-05-17 2022-09 /pmc/articles/PMC9110932/ /pubmed/35581351 http://dx.doi.org/10.1038/s41423-022-00870-5 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
| spellingShingle | Correspondence Arora, Prerna Kempf, Amy Nehlmeier, Inga Graichen, Luise Schulz, Sebastian Cossmann, Anne Dopfer-Jablonka, Alexandra Winkler, Martin S. Jäck, Hans-Martin Behrens, Georg M. N. Pöhlmann, Stefan Hoffmann, Markus Efficient antibody evasion but reduced ACE2 binding by the emerging SARS-CoV-2 variant B.1.640.2 |
| title | Efficient antibody evasion but reduced ACE2 binding by the emerging SARS-CoV-2 variant B.1.640.2 |
| title_full | Efficient antibody evasion but reduced ACE2 binding by the emerging SARS-CoV-2 variant B.1.640.2 |
| title_fullStr | Efficient antibody evasion but reduced ACE2 binding by the emerging SARS-CoV-2 variant B.1.640.2 |
| title_full_unstemmed | Efficient antibody evasion but reduced ACE2 binding by the emerging SARS-CoV-2 variant B.1.640.2 |
| title_short | Efficient antibody evasion but reduced ACE2 binding by the emerging SARS-CoV-2 variant B.1.640.2 |
| title_sort | efficient antibody evasion but reduced ace2 binding by the emerging sars-cov-2 variant b.1.640.2 |
| topic | Correspondence |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9110932/ https://www.ncbi.nlm.nih.gov/pubmed/35581351 http://dx.doi.org/10.1038/s41423-022-00870-5 |
| work_keys_str_mv | AT aroraprerna efficientantibodyevasionbutreducedace2bindingbytheemergingsarscov2variantb16402 AT kempfamy efficientantibodyevasionbutreducedace2bindingbytheemergingsarscov2variantb16402 AT nehlmeieringa efficientantibodyevasionbutreducedace2bindingbytheemergingsarscov2variantb16402 AT graichenluise efficientantibodyevasionbutreducedace2bindingbytheemergingsarscov2variantb16402 AT schulzsebastian efficientantibodyevasionbutreducedace2bindingbytheemergingsarscov2variantb16402 AT cossmannanne efficientantibodyevasionbutreducedace2bindingbytheemergingsarscov2variantb16402 AT dopferjablonkaalexandra efficientantibodyevasionbutreducedace2bindingbytheemergingsarscov2variantb16402 AT winklermartins efficientantibodyevasionbutreducedace2bindingbytheemergingsarscov2variantb16402 AT jackhansmartin efficientantibodyevasionbutreducedace2bindingbytheemergingsarscov2variantb16402 AT behrensgeorgmn efficientantibodyevasionbutreducedace2bindingbytheemergingsarscov2variantb16402 AT pohlmannstefan efficientantibodyevasionbutreducedace2bindingbytheemergingsarscov2variantb16402 AT hoffmannmarkus efficientantibodyevasionbutreducedace2bindingbytheemergingsarscov2variantb16402 |